title: Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters.
abstract: BACKGROUND
  The hepatitis B virus is an important healthcare problem. According to current clinical practice, a liver biopsy is required for the diagnosis and treatment of chronic liver disease. However, a liver biopsy is an invasive, inconvenient procedure, which requires an expert pathologist opinion. Therefore requirement of biochemical tests, which are considered to indicate hepatic fibrosis and may be repeated easily, increases gradually today.
  
  
  OBJECTIVE
  This study evaluated the correlation between hepatic fibrosis and routine laboratory values in patients with chronic hepatitis B.
  
  
  METHODS
  The files of 456 patients with CHB (chronic hepatitis B) who were referred to the infectious diseases and clinical microbiology clinic between January 2009 and March 2012 were screened retrospectively. Liver biopsy samples were examined according to Ishak scoring. Laboratory parameters and histopathology reports were recorded, and correlations between the fibrosis grade and laboratory parameters were analyzed.
  
  
  RESULTS
  There were 320 male and 136 female patients, with a mean age 36.7 ± 12.1 years. According to liver biopsy results, a low fibrosis score (stage 0-2) was detected in 281 patients (61.6%), and a high fibrosis score (stage 3-5) was detected in 175 patients (38.4%). Patients with a high fibrosis score had significantly higher ALT (alanine amino transferase), AST (aspartate aminotransferase), and HBV-DNA values and a significantly lower platelet count compared with those with a low fibrosis score (P = 0.001, 0.001, 0.025, and 0.001, respectively). A positive correlation was detected between the fibrosis score and age, BMI, HAI, ALT, and AST values, and a negative correlation was detected between the fibrosis score and albumin and platelet counts. In the regression analysis performed to evaluate the factors associated with high-stage fibrosis, fibrosis was determined to be associated with thrombosis, ALT, and gender. The results of the regression analysis demonstrated that the risk of fibrosis was 4.6 fold higher in men.
  
  
  CONCLUSIONS
  According to the results obtained in our study, advanced age, higher BMI, AST, ALT, and HBV-DNA levels, and low albumin and platelet levels are correlated with advanced fibrosis in patients with CHB.
authors.affiliation: Infectious Diseases and Clinical Microbiology Department, Selcuk University, Konya, Turkey.
authors.forename: Nazlim
authors.initials: N
authors.lastname: Aktug Demir
authors.affiliation: Infectious Diseases and Clinical Microbiology Department, Adiyaman University, Adiyaman, Turkey.
authors.forename: Servet
authors.initials: S
authors.lastname: Kolgelier
authors.affiliation: Infectious Diseases and Clinical Microbiology Department, Konya State Hospital, Konya, Turkey.
authors.forename: Serap
authors.initials: S
authors.lastname: Ozcimen
authors.affiliation: Gastroenterology Department, Konya Education and Training Hospital, Konya, Turkey.
authors.forename: Gokhan
authors.initials: G
authors.lastname: Gungor
authors.affiliation: Infectious Diseases and Clinical Microbiology Department, Selcuk University, Konya, Turkey.
authors.forename: Sua
authors.initials: S
authors.lastname: Sumer
authors.affiliation: Public Health Department, Necmettin Erbakan University, Konya, Turkey.
authors.forename: Lutfi
authors.initials: L
authors.lastname: Saltuk Demir
authors.affiliation: Infectious Diseases and Clinical Microbiology Department, Hacettepe University, Ankara, Turkey.
authors.forename: Ahmet Cagkan
authors.initials: AC
authors.lastname: Inkaya
authors.affiliation: Infectious Diseases and Clinical Microbiology Department, Selcuk University, Konya, Turkey.
authors.forename: Onur
authors.initials: O
authors.lastname: Ural
keywords: Biological Markers; Hepatitis B, Chronic; Liver Cirrhosis
references.citation: Comp Hepatol. 2005 Jul 11;4:6
references.pmid: 16008833
references.citation: Am J Gastroenterol. 2001 Mar;96(3):918-9
references.pmid: 11280581
references.citation: Rev Esp Cardiol. 1990 Mar;43(3):201-2
references.pmid: 2333407
references.citation: World J Gastroenterol. 2003 Dec;9(12):2796-800
references.pmid: 14669336
references.citation: J Hepatol. 1995 Jun;22(6):696-9
references.pmid: 7560864
references.citation: J Hepatol. 2006 Oct;45(4):529-38
references.pmid: 16879891
references.citation: Am J Gastroenterol. 2006 Nov;101(11):2537-45
references.pmid: 17029616
references.citation: Am J Gastroenterol. 2006 Mar;101(3):547-55
references.pmid: 16542291
references.citation: World J Gastroenterol. 1999 Aug;5(4):301-304
references.pmid: 11819452
references.citation: Hepatology. 2003 Aug;38(2):518-26
references.pmid: 12883497
references.citation: Aliment Pharmacol Ther. 2009 Sep 15;30(6):557-76
references.pmid: 19519733
references.citation: Aliment Pharmacol Ther. 2005 Nov 1;22(9):769-74
references.pmid: 16225484
references.citation: Hepatology. 2011 Mar;53(3):726-36
references.pmid: 21319189
references.citation: Am J Gastroenterol. 2004 Jun;99(6):1160-74
references.pmid: 15180741
references.citation: Comp Hepatol. 2004 Jan 14;3 Suppl 1:S1
references.pmid: 14960153
references.citation: Clin Chem. 2004 Aug;50(8):1344-55
references.pmid: 15192028
references.citation: Am J Gastroenterol. 2005 Mar;100(3):616-23
references.pmid: 15743360
references.citation: Aliment Pharmacol Ther. 2004 Aug 1;20(3):249-59
references.pmid: 15274661